| PERIOD ENDING | 29-Jun-08 | 30-Mar-08 | 30-Dec-07 | 30-Sep-07 | | Total Revenue | 313,014 | 302,854 | 320,637 | 324,213 | | Cost of Revenue | 220,527 | 212,910 | 209,804 | 217,502 | | | Gross Profit | 92,487 | 89,944 | 110,833 | 106,711 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 66,587 | 65,446 | 69,762 | 62,938 | | Non Recurring | (41) | 448 | (35,767) | 1,807 | | Others | 17,693 | 15,993 | 18,911 | 20,022 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,248 | 8,057 | 57,927 | 21,944 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,975) | (70,487) | 5,289 | 18 | | Earnings Before Interest And Taxes | 273 | (62,430) | 63,216 | 21,962 | | Interest Expense | 13,944 | 13,491 | 15,167 | 15,489 | | Income Before Tax | (13,671) | (75,921) | 48,049 | 6,473 | | Income Tax Expense | (6,766) | (8,464) | 16,031 | 4,174 | | Minority Interest |
-
| (14) | 150 | 1,432 | | | | Net Income From Continuing Ops | (6,905) | (67,471) | 32,168 | 3,731 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 1,144 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,905) | (67,471) | 33,312 | 3,731 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,905) | ($67,471) | $33,312 | $3,731 |
|
1.49% Nasdaq 
0.27%
Income Statement
